Literature DB >> 26417670

Oxidative stress promotes benign prostatic hyperplasia.

Paz Vital1, Patricia Castro1, Michael Ittmann1.   

Abstract

BACKGROUND: Benign prostatic hyperplasia (BPH) is characterized by increased tissue mass in the transition zone of the prostate, which leads to obstruction of urine outflow and significant morbidity in the majority of older men. Plasma markers of oxidative stress are increased in men with BPH but it is unclear whether oxidative stress and/or oxidative DNA damage are causal in the pathogenesis of BPH.
METHODS: Levels of 8-OH deoxyguanosine (8-OH dG), a marker of oxidative stress, were measured in prostate tissues from normal transition zone and BPH by ELISA. 8-OH dG was also detected in tissues by immunohistochemistry and staining quantitated by image analysis. Nox4 promotes the formation of reactive oxygen species. We therefore created and characterized transgenic mice with prostate specific expression of Nox4 under the control of the prostate specific ARR2PB promoter.
RESULTS: Human BPH tissues contained significantly higher levels of 8-OH dG than control transition zone tissues and the levels of 8-OH dG were correlated with prostate weight. Cells with 8-OH dG staining were predominantly in the epithelium and were present in a patchy distribution. The total fraction of epithelial staining with 8-OH dG was significantly increased in BPH tissues by image analysis. The ARR2PB-Nox4 mice had increased oxidative DNA damage in the prostate, increased prostate weight, increased epithelial proliferation, and histological changes including epithelial proliferation, stromal thickening, and fibrosis when compared to wild type controls.
CONCLUSIONS: Oxidative stress and oxidative DNA damage are important in the pathogenesis of BPH.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Nox4; benign prostatic hyperplasia; oxidative DNA damage; oxidative stress; transgenic

Mesh:

Substances:

Year:  2015        PMID: 26417670      PMCID: PMC5469601          DOI: 10.1002/pros.23100

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  33 in total

1.  The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells.

Authors:  Junya Kuroda; Kazunori Nakagawa; Tomoko Yamasaki; Kei-ichiro Nakamura; Ryu Takeya; Futoshi Kuribayashi; Shinobu Imajoh-Ohmi; Kazuhiko Igarashi; Yosaburo Shibata; Katsuo Sueishi; Hideki Sumimoto
Journal:  Genes Cells       Date:  2005-12       Impact factor: 1.891

2.  Morphometric analysis of pediatric and nonhyperplastic prostate glands: evidence that BPH is not a unique stromal process.

Authors:  E Shapiro; V Hartanto; E J Perlman; R Tang; B Wang; H Lepor
Journal:  Prostate       Date:  1997-11-01       Impact factor: 4.104

Review 3.  Prostatic fibrosis, lower urinary tract symptoms, and BPH.

Authors:  Jose A Rodriguez-Nieves; Jill A Macoska
Journal:  Nat Rev Urol       Date:  2013-07-16       Impact factor: 14.432

4.  Interleukin-1alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia.

Authors:  D Giri; M Ittmann
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

5.  Oxidative stress--cause or consequence of male genital tract disorders?

Authors:  Tiiu Kullisaar; Silver Türk; Margus Punab; Reet Mändar
Journal:  Prostate       Date:  2011-10-24       Impact factor: 4.104

6.  Identification of renox, an NAD(P)H oxidase in kidney.

Authors:  M Geiszt; J B Kopp; P Várnai; T L Leto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

7.  Aging-associated changes in gene expression in the ACI rat prostate: Implications for carcinogenesis.

Authors:  Ismael Reyes; Niradiz Reyes; Michael Iatropoulos; Abraham Mittelman; Jan Geliebter
Journal:  Prostate       Date:  2005-05-01       Impact factor: 4.104

8.  The effects of aging on the molecular and cellular composition of the prostate microenvironment.

Authors:  Daniella Bianchi-Frias; Funda Vakar-Lopez; Ilsa M Coleman; Stephen R Plymate; May J Reed; Peter S Nelson
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

9.  Oxidative stress in benign prostate hyperplasia.

Authors:  M Aryal; A Pandeya; N Gautam; N Baral; M Lamsal; S Majhi; L Chandra; R Pandit; B K L Das
Journal:  Nepal Med Coll J       Date:  2007-12

10.  Evaluation of oxidative stress and DNA damage in benign prostatic hyperplasia patients and comparison with controls.

Authors:  Manzoor Ahmad; Nida Suhail; Tariq Mansoor; Naheed Banu; Shamshad Ahmad
Journal:  Indian J Clin Biochem       Date:  2012-06-12
View more
  25 in total

1.  Spatiotemporal Proteomics Reveals the Molecular Consequences of Hormone Treatment in a Mouse Model of Lower Urinary Tract Dysfunction.

Authors:  Samuel Thomas; Ling Hao; Kellen DeLaney; Dalton McLean; Laura Steinke; Paul C Marker; Chad M Vezina; Lingjun Li; William A Ricke
Journal:  J Proteome Res       Date:  2020-03-16       Impact factor: 4.466

Review 2.  Smoking habits and benign prostatic hyperplasia: A systematic review and meta-analysis of observational studies.

Authors:  Huan Xu; Shi Fu; Yanbo Chen; Qi Chen; Meng Gu; Zhong Wang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

3.  CD8+ T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway.

Authors:  Yang Yang; Shuai Hu; Jie Liu; Yun Cui; Yu Fan; Tianjing Lv; Libo Liu; Jun Li; Qun He; Wenke Han; Wei Yu; Yin Sun; Jie Jin
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

4.  Prostatic vascular damage induced by cigarette smoking as a risk factor for recovery after holmium laser enucleation of the prostate (HoLEP).

Authors:  Huan Xu; Chong Liu; Meng Gu; Yanbo Chen; Zhikang Cai; Qi Chen; Zhong Wang
Journal:  Oncotarget       Date:  2017-02-21

5.  Anti-Inflammatory and Antimicrobial Effects of a Novel Herbal Formulation (WSY-1075) in a Chronic Bacterial Prostatitis Rat Model.

Authors:  Jung Woo Park; Hyun Cheol Jeong; Hyong Woo Moon; Shin Jay Cho; Jong Hyup Yang; Woo Hyun Kim; Woong Jin Bae; Jin Bong Choi; Hyuk Jin Cho; U-Syn Ha; Sung Hoo Hong; Ji Youl Lee; Sae Woong Kim
Journal:  World J Mens Health       Date:  2016-12-22       Impact factor: 5.400

6.  Potential role of glutathione S-transferase P1 gene polymorphism and metabolic syndrome in lower urinary tract symptoms attributed to benign prostatic hyperplasia.

Authors:  Wenjun Zhang; Zheming Li; Miao Liu; Yi Mu; Jun He; Pan Chen; Dongdong Liu; Kehang Chen; Bangwei Che; Shenghan Xu; Hongyan Zhang; Kaifa Tang
Journal:  World J Urol       Date:  2021-07-06       Impact factor: 4.226

Review 7.  The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective.

Authors:  Teow J Phua
Journal:  Medicines (Basel)       Date:  2021-06-11

8.  Inhibitory Effect of Yongdamsagan-Tang Water Extract, a Traditional Herbal Formula, on Testosterone-Induced Benign Prostatic Hyperplasia in Rats.

Authors:  Eunsook Park; Mee-Young Lee; Woo-Young Jeon; Nari Lee; Chang-Seob Seo; Hyeun-Kyoo Shin
Journal:  Evid Based Complement Alternat Med       Date:  2016-07-18       Impact factor: 2.629

9.  The effect of Bongardia Chrysogonum on prostate tissue in a rat model of STZ-induced diabetes.

Authors:  Recep Dokuyucu; Kerem Han Gozukara; Oguzhan Ozcan; Nebihat Kaplan Sefil; Ahmet Nacar; Ahmet Dokuyucu; Mehmet Inci
Journal:  Springerplus       Date:  2016-08-11

10.  Prevalence and risk factors of lower urinary tract symptoms in Chinese adult men: a multicentre cross-sectional study.

Authors:  Meng Rao; Huangfang Shangguan; Zhengyan Zeng; Yi Zheng; Huiping Zhang; Honggang Li; Wei Xia; Changhong Zhu; Chengliang Xiong; Huangtao Guan
Journal:  Oncotarget       Date:  2017-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.